Get started
Author

Toshiaki Takahashi

Observed name: T. Takahashi
ORCID: 0009-0003-0364-539X
Observed ORCID: 0009-0003-0364-539X
OpenAlex ID: A5126266388
Infusion-Related Reactions from Immune Checkpoint Inhibitors in Solid Tumors: A Proportional and Network Meta-Analysis
2026 · Yu Fujiwara, Toshiaki Takahashi, et al. · Targeted Oncology · 2
Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis
2026 · Yu Fujiwara, Yui Okamura, et al. · JNCI Cancer Spectrum · 1
Flare incidences of pre-existing rheumatologic diseases in patients with solid tumors receiving immune checkpoint inhibitors: A systematic review and meta-analysis
2026 · Kenji Yamada, Takemichi Matsui, et al. · Seminars in Arthritis and Rheumatism · 1
Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
2026 · Jacob Sands, Shun Lu, et al. · Targeted Oncology
PDF
Incidence and treatment-modifying impact of immune checkpoint inhibitor–associated peripheral edema: a systematic review and meta-analysis
2026 · Anneliese Markus, Kazuya Tsuchiya, et al. · JNCI Cancer Spectrum
Abstract 914: Racial disparities in immune-related adverse events with immune checkpoint inhibitors: A systematic review and meta-analysis.
2026 · Toshiaki Takahashi, Yu Fujiwara, et al. · Cancer Research
Abstract PS1-05-08: Incidence and predictors of interstitial lung disease associated with antibody-drug conjugates in breast cancer: a systematic review and meta-analysis
2026 · H. S. Wenning, T. Takahashi, et al. · Clinical Cancer Research
Works count: 7
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type